Abstract Objective To study the mutation types of factor VIII (FVIII) gene in patients from 7 hemophilia A (HA) families and the relationship between FVIII gene mutations and clinical phenotypes.Methods A total of 8 patients from 7 HA families were recruited. The activated partial thromboplastin time (APTT) and factor VIII coagulant activity (VIII:C) in these patients were measured. Polymerase chain reaction (PCR) was performed to analyze FVIII gene intron 1 and 22 inversions. For patients without the FVIII intron inversions, direct sequencing was performed to determine their mutation types and other related members of their families were also tested by PCR and sequencing to analyze the corresponding mutation sites.Results The ranges of APTT and VIII:C of the 8 patients were 91.6-131 seconds and 0.8%-2%, respectively. FVIII gene intron 22 inversion was not detected, while intron 1 inversion was detected in one patient. There were 5 types of mutations in FVIII gene detected in the remaining 7 patients, including 6 patients with mutations in exon 14 and 1 patient with mutation in exon 23; all of the 5 types of mutations were single nucleotide mutations. Among the detected mutations in FVIII gene, p.His1202LeufsX16 (c.3666delA) detected in one patient was found to be a previously unreported mutation in FVIII gene.Conclusions FVIII gene exon 14 is a hot-spot mutation region and p.His1202LeufsX16 is found to be a novel mutation in FVIII gene.
LIANG Wei-Ling,WEI Hong-Ying,LIAO Ning et al. Relationship between genotypes and clinical phenotypes in patients from 7 hemophilia A families[J]. CJCP, 2015, 17(9): 903-907.
LIANG Wei-Ling,WEI Hong-Ying,LIAO Ning et al. Relationship between genotypes and clinical phenotypes in patients from 7 hemophilia A families[J]. CJCP, 2015, 17(9): 903-907.
Keeney S, Mitchell M, Goodeve A. The molecular analysis of haemophilia A:a guideline from the UK haemophilia centre doctors, organization haemophilia genetics laboratory network[J]. Haemophilia, 2005, 11(4):387-397.
Liu Q, Nozari G, Sommer SS. Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A[J]. Blood, 1998, 92(4):1458-1459.
Viel KR, Machiah DK, Warren DM, et al. A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels[J]. Blood, 2007, 109(9):3713-3724.
[9]
Lin SY, Su YN, Hung CC, et al. Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM[J]. BMC Med Genet, 2008, 9:53.
[10]
Bagnall RD, Waseem N, Green PM, et al. Recurrent inversion breaking intron l of the factor VIII gene is a frequent cause of severe hemophilia A[J]. Blood, 2002, 99(1):168-174.
[11]
Nadja B, Ameni M, Reswith E, et al. Spectmm of molecular defects and mutation deteetion rate in patients with mild and moderate hemophilia A[J]. Hum Mutat, 2007, 28(1):54-60.
[12]
Zimmermann MA, Oldenburg J, Müller CR, et al. Unusual genomic rearrangements in introns 1 and 22 of the F8 gene[J]. Hamostaseologie, 2011, 31 Suppl 1:S69-S73.
[13]
Bogdanova N, Markoff A, Pollmann H, et al. Prevalence of small rearrangements in the factor VIII gene F8C among patients with severe hemophilia A[J]. Hum Mutat, 2002, 20(3):236-237.
[14]
Pelak K, Shianna KV, Ge D, et al. The characterization of twenty sequenced human genomes[J]. PLoS Genet, 2010, 6(9):e1001111.
[15]
Santacroce R, Acquila M, Belvini D, et al. Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A[J]. J Hum Genet, 2008, 53(3):275-284.
